KR100411021B1 - A drink containing the red ginseng, and a method for preparing thereof - Google Patents
A drink containing the red ginseng, and a method for preparing thereof Download PDFInfo
- Publication number
- KR100411021B1 KR100411021B1 KR10-2001-0068353A KR20010068353A KR100411021B1 KR 100411021 B1 KR100411021 B1 KR 100411021B1 KR 20010068353 A KR20010068353 A KR 20010068353A KR 100411021 B1 KR100411021 B1 KR 100411021B1
- Authority
- KR
- South Korea
- Prior art keywords
- red ginseng
- weight
- concentrate
- herbal
- pycnogenol
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 68
- 238000000034 method Methods 0.000 title claims abstract description 12
- 239000012141 concentrate Substances 0.000 claims abstract description 33
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000008213 purified water Substances 0.000 claims abstract description 22
- 229920002770 condensed tannin Polymers 0.000 claims abstract description 21
- 241000411851 herbal medicine Species 0.000 claims abstract description 21
- 235000018192 pine bark supplement Nutrition 0.000 claims abstract description 21
- 229940106796 pycnogenol Drugs 0.000 claims abstract description 21
- 235000013361 beverage Nutrition 0.000 claims abstract description 15
- 229960003080 taurine Drugs 0.000 claims abstract description 15
- 239000004615 ingredient Substances 0.000 claims abstract description 12
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 9
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 9
- 239000011720 vitamin B Substances 0.000 claims abstract description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 7
- 239000008369 fruit flavor Substances 0.000 claims abstract description 7
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 239000003765 sweetening agent Substances 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 27
- 238000000605 extraction Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 241000208340 Araliaceae Species 0.000 claims description 6
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 229960002920 sorbitol Drugs 0.000 claims description 5
- 239000012676 herbal extract Substances 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 9
- 230000003712 anti-aging effect Effects 0.000 abstract description 7
- 206010027304 Menopausal symptoms Diseases 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 235000006708 antioxidants Nutrition 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 6
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 5
- 235000010358 acesulfame potassium Nutrition 0.000 description 5
- 239000000619 acesulfame-K Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 240000002045 Guettarda speciosa Species 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000008122 artificial sweetener Substances 0.000 description 4
- 235000021311 artificial sweeteners Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 244000307700 Fragaria vesca Species 0.000 description 3
- 235000016623 Fragaria vesca Nutrition 0.000 description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 3
- 235000011034 Rubus glaucus Nutrition 0.000 description 3
- 244000235659 Rubus idaeus Species 0.000 description 3
- 235000009122 Rubus idaeus Nutrition 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 231100000544 menstrual irregularity Toxicity 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229940032362 superoxide dismutase Drugs 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- SWMBOMMGMHMOHE-QQLCCCKISA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SWMBOMMGMHMOHE-QQLCCCKISA-N 0.000 description 1
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 1
- SQWFNVMZGIOFHT-UHFFFAOYSA-N 2,2-bis(4-methoxyphenyl)-5,6-dimethylbenzo[h]chromene Chemical compound C1=CC(OC)=CC=C1C1(C=2C=CC(OC)=CC=2)C=CC(C(C)=C(C)C=2C3=CC=CC=2)=C3O1 SQWFNVMZGIOFHT-UHFFFAOYSA-N 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 229920001991 Proanthocyanidin Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000010204 pine bark Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/02—Antioxidant
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
Landscapes
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
본 발명은 홍삼음료 및 그의 제조방법에 관한 것으로, 좀더 상세하게는 홍삼농축액과 생약재, 피크노제놀, 타우린 등과 같은 항산화작용 증진제를 함유하여 노화억제 및 여성들의 혈허(血虛)로 인한 갱년기증상 완화기능을 갖는 홍삼음료 및 그의 제조방법에 관한 것이다.The present invention relates to a red ginseng beverage and a method for manufacturing the same, and more specifically, to contain the red ginseng concentrate and herbal medicines, antioxidants such as pycnogenol, taurine, etc. to relieve menopausal symptoms due to anti-aging and blood loss of women It relates to a red ginseng drink having and a manufacturing method thereof.
본 발명은 홍삼농축액 1∼3 중량% (w/v), 생약성분 농축액 2∼6 중량% (w/v), 피크노제놀 0.05∼0.2 중량% (w/v), D-솔비톨 10∼20 중량% (w/v), 타우린 1∼3 중량% (w/v), 감미료 0.01∼0.05 중량% (w/v), 비타민 B군 0.01∼0.06 중량% (w/v), 과실향 0.05∼0.15 중량%(w/v) 및 정제수로 구성된 홍삼음료 및 그의 제조방법을 제공한다.Red ginseng concentrate 1 to 3% by weight (w / v), herbal ingredient concentrate 2 to 6% by weight (w / v), pycnogenol 0.05 to 0.2% by weight (w / v), D- sorbitol 10 to 20% by weight (w / v), taurine 1-3 wt% (w / v), sweetener 0.01-0.05 wt% (w / v), vitamin B group 0.01-0.06 wt% (w / v), fruit flavor 0.05-0.15 weight It provides a red ginseng drink and a method of manufacturing the same consisting of% (w / v) and purified water.
Description
본 발명은 홍삼음료 및 그의 제조방법에 관한 것으로, 좀더 상세하게는 홍삼농축액과 생약재, 피크노제놀, 타우린 등과 같은 항산화작용 증진제를 함유하여 노화억제 및 여성들의 혈허(血虛)로 인한 갱년기증상 완화기능을 갖는 홍삼음료 및 그의 제조방법에 관한 것이다.The present invention relates to a red ginseng beverage and a method for manufacturing the same, and more specifically, to contain the red ginseng concentrate and herbal medicines, antioxidants such as pycnogenol, taurine, etc. to relieve menopausal symptoms due to anti-aging and blood loss of women It relates to a red ginseng drink having and a manufacturing method thereof.
현대를 살아가는데 있어서 인간은 각종 스트레스, 공해, 자연발생적인 노화 현상 등으로 인하여 면역력이 저하되고 노화가 진행되게 된다. 특히 여성들은 40대 이후 서서히 시작되는 갱년기 장애까지 동반되면서 생리불순과 피부가 거칠어지고 안색이 나빠지는 등의 증상이 나타난다.In the modern life, humans are deprived of immunity due to various stresses, pollution, and naturally occurring aging phenomena, and aging proceeds. In particular, women are accompanied by menopausal disorders, which gradually begin after the age of 40, with symptoms such as menstrual irregularities, rough skin, and complexion.
활성산소는 몸에서 해로운 작용을 하는 산소를 말하는 것으로, 산소는 인간에게 없어서는 안될 중요한 물질로서 우리가 호흡을 할 때 체내에 흡수되어 세포 안에서 에너지를 생성하는 역할을 한다. 이때 흡수된 산소의 일부가 체내에서 화학반응을 일으켜 독성을 갖는 성분으로 변성되는데, 이러한 독성이 있는 산소가 바로 활성산소이다. 이렇게 변성되는 이유는 대기 오염물질속의 프레온가스, 배기가스, 식품첨가물, 식품과산화물, 화학약품, 자외선, 전자파, 스트레스, 인공합성 화학물질로 만든 약품 등에 기인하는 것으로, 활성산소는 세포와 염색체까지도 변질시키는 강력한 산화력을 가지고 있어 몸을 병들게 하고 노화를 촉진시키게 된다.Free radicals are oxygen that has a harmful effect on the body. Oxygen is an indispensable substance for humans. It is absorbed by the body when we breathe and generates energy in cells. At this time, some of the absorbed oxygen causes chemical reactions in the body to denature to toxic components, which is oxygen that is toxic. The denaturation is caused by freon gas, exhaust gas, food additives, food peroxides, chemicals, ultraviolet rays, electromagnetic waves, stress, and chemicals made of synthetic synthetic chemicals in the air pollutants. It has a strong oxidizing power that makes your body sick and promotes aging.
인체의 몸에는 활성산소를 제거하는 슈퍼 옥사이드 디스뮤타제(Super Oxide Dismutase, SOD)라는 생리활성 효소가 있지만, 산화에 대항하는 능력을 증가시키는데 가장 효과적인 것은 항산화 물질(scavenger)을 다량 함유하는 식품을 섭취하는 방법이다.The human body has a physiologically active enzyme called Super Oxide Dismutase (SOD) that removes free radicals, but the most effective in increasing its ability to fight oxidation is to use foods that contain large amounts of antioxidants. How to eat.
인삼(ginseng)은 고대로부터 남녀의 모든 허증(虛症), 신체허약을 신속히 회복시켜주며 인체 오장육부의 기능을 보충하여 준다고 알려져 왔다. 또한 체내의 독소를 제거해 주고 대사기능 부전으로 인하여 발생되기 쉬운 병에 대하여 저항력을 증진시켜 주며, 피부의 기능을 정상화시키고 종양에 대하여도 탁월한 효능을 지니고 있는 것으로 알려져 왔다.Ginseng (ginseng) has been known since ancient times to quickly restore all the weakness and physical weakness of men and women and to supplement the function of the five human viscera. In addition, it has been known to remove toxins in the body and improve resistance to diseases that are likely to occur due to metabolic insufficiency, normalize skin function, and have excellent effects on tumors.
홍삼의 노화방지 효능에 대한 연구에 의하면 조직의 퇴행성변화에 중요한 역할을 하는 활성산소(O2 -, H2O2, OH-, O2)중의 유해작용을 홍삼의 비사포닌 성분이 억제한다고 하였으며, 이는 O2 -에 대한 인삼의 소진(消盡)효과에 기인한다고 보고(서울대 의대 학술지 1984)되었고, 홍삼중 노화억제 물질로서 수종의 페놀성 화합물과 말톨성분의 존재를 밝히고 이들 성분은 항피로 효과도 있는 것으로 보고되었다(중국동양의학 심포지움 1985).According to the study of the anti-aging efficacy of red ginseng free radicals play an important role in the degeneration of the tissue (O 2 -, H 2 O 2, OH -, O 2) was to inhibit the non-saponin components of the harmful effects of red ginseng , which is O 2 - reported to be due to the run out (消盡) effect of ginseng on (Seoul National University School of Medicine journal, 1984) was, hongsamjung as aging inhibitors reveal the existence of phenolic compounds and maltol components of the species of these components is effective exhaustion wherein It was also reported (Chinese Oriental Medical Symposium 1985).
피크노제놀(pycnogenol)은 프랑스 보르도 지방의 해안에 생육하는 소나무의 껍질 추출물에서 인체에 유익한 항산화 물질을 다량 함유하고 있는 유효성분을 분리 정제한 것으로, 미국특허 제 4,698,360호에 혈전증, 집중력 결여과잉운동 증후군, 심장병, 뇌졸중에 대한 효과가 있는 것으로 개시되어 있는데 지금까지의 임상연구 결과에 의하면 무독성, 무변이성, 무발암성인 것으로 실증되었다.Pycnogenol (Pycnogenol) is an isolated and purified active ingredient containing a large amount of antioxidants beneficial to the human body from the extract of pine bark growing on the coast of Bordeaux, France, US Patent No. 4,698,360 thrombosis, lack of concentration hyperactivity syndrome, It has been shown to have an effect on heart disease and stroke. Until now, clinical studies have shown that it is nontoxic, mutagenic, and carcinogenic.
피크노제놀이 강력한 활성산소 제거물질인 이유는 주성분이 강력한 항산화물질인 플라보노이드(flavonoid)로 구성되어 있기 때문인데, 피크노제놀에 함유된 플라보노이드는 폴리페놀 중의 플라보노이드류에 속하는 것으로서 프로안토시아니딘 (proanthocyanidin), 카테친(catechin), 에피카친(epicathin) 등 유익한 폴리페놀류 이다. 또한, 피크노제놀은 유기산을 40종이상 함유한 항산화제로서 100% 수용성이고 체내에서 빠르게 흡수되는 물질로 알려져 있다.Pycnogenol is a potent free radical scavenger because its main component is composed of flavonoids, which are powerful antioxidants. Flavonoids in pycnogenol belong to the flavonoids in polyphenols, proanthocyanidin, These are useful polyphenols such as catechin and epicathin. Pycnogenol is an antioxidant containing more than 40 organic acids and is known to be 100% water soluble and rapidly absorbed by the body.
홍삼성분이 함유된 음료에 대해서는 참다래를 주성분으로 하고 홍삼 및 당이 첨가된 참다래 홍삼 탄산음료(한국공개특허 제 1996-9697호)와 홍삼액과 당이 내포되고 표면에 홍삼분말이 도포되어 있는 인삼정과(한국공개특허 제 2001-35323호) 등이 개시되어 있으나, 이러한 선행기술은 홍삼성분에 단순히 당을 첨가하여 홍삼의 기호성을 개선시킨 음료에 불과한 것이다.For beverages containing red ginseng components, Ginseng berry red ginseng carbonated beverage (Korean Laid-Open Patent No. 1996-9697), red ginseng liquid and sugar containing red ginseng and sugars, and red ginseng powder coated on the surface (Korean Patent Publication No. 2001-35323) and the like, but the prior art is merely a beverage that improves the palatability of red ginseng by simply adding sugar to the red ginseng component.
이에 본 발명자들은 홍삼의 응용범위를 넓히기 위한 연구를 수행하여 홍삼농축액에 생약재, 피크노제놀, 타우린 등과 같은 항산화작용 증진제를 첨가하여 홍삼의 노화방지효과에 상승작용을 일으킬 수 있는 홍삼음료를 제조할 수 있음을 알아내고 본 발명을 완성하였다.Therefore, the present inventors have conducted research to broaden the application range of red ginseng, and can prepare red ginseng beverages that can cause synergistic effects on anti-aging effects of red ginseng by adding antioxidants such as herbal medicine, pycnogenol, taurine, etc. to red ginseng concentrate. The present invention was completed.
따라서, 본 발명의 목적은 홍삼농축액과 생약재, 피크노제놀, 타우린 등과 같은 항산화작용 증진제를 함유하여 노화억제 및 여성들의 혈허로 인한 갱년기증상 완화기능을 갖는 홍삼음료를 제공함에 있다.Accordingly, an object of the present invention is to provide a red ginseng beverage having red ginseng concentrate and antioxidants such as herbal medicine, pycnogenol, taurine and the like to relieve menopausal symptoms due to anti-aging and blood loss of women.
본 발명의 또다른 목적은 홍삼농축액과 생약재, 피크노제놀, 타우린 등과 같은 항산화작용 증진제를 함유하여 노화억제 및 여성들의 혈허로 인한 갱년기증상 완화기능을 갖는 홍삼음료의 제조방법을 제공함에 있다.It is another object of the present invention to provide a method for preparing red ginseng drink having anti-aging effect and relieving menopausal symptoms due to blood loss of women by containing red ginseng concentrate and herbal medicine, pycnogenol, taurine and the like.
본 발명은 홍삼농축액 1∼3 중량% (w/v), 생약성분 농축액 2∼6 중량% (w/v), 피크노제놀 0.05∼0.2 중량% (w/v), D-솔비톨 10∼20 중량% (w/v), 타우린 1∼3 중량% (w/v), 감미료 0.01∼0.05 중량% (w/v), 비타민 B군 0.01∼0.06 중량% (w/v), 과실향 0.05∼0.15 중량%(w/v) 및 정제수로 구성된 홍삼음료 임을 특징으로 한다.Red ginseng concentrate 1 to 3% by weight (w / v), herbal ingredient concentrate 2 to 6% by weight (w / v), pycnogenol 0.05 to 0.2% by weight (w / v), D- sorbitol 10 to 20% by weight (w / v), taurine 1-3 wt% (w / v), sweetener 0.01-0.05 wt% (w / v), vitamin B group 0.01-0.06 wt% (w / v), fruit flavor 0.05-0.15 weight It is characterized in that the red ginseng drink consisting of% (w / v) and purified water.
본 발명에 사용되는 홍삼농축액은 홍삼의 동체와 미삼을 80 : 20의 비율로 혼합하여 정제수를 홍삼대비 5-10배량 가하고 70-90℃에서 7-9시간 동안 추출하여 냉각시키는 공정을 3회 반복하여 얻어진 각각의 추출액을 혼합하여 8,000rpm으로 10-20분 동안 원심분리한 후, 65℃ 이하에서 감압농축시킨 것으로 수분함량이 36-40%인 추출액을 사용하는 것이 바람직한데, 홍삼농축액을 3 중량% (w/v) 이상 사용하면 고미가 강하고 침전발생등 문제가 있고, 1 중량% (w/v) 이하로 사용하면 홍삼고유의 향취미를 인지하지 못하고 효능이 감소될 수 있는 문제가 발생한다.The red ginseng concentrate used in the present invention is a mixture of the red ginseng body and the ginseng at a ratio of 80:20, adding 5-10 times the purified water to the red ginseng and extracting and cooling the mixture for 7-9 hours at 70-90 ° C. three times. Each extract obtained by mixing was centrifuged at 8,000 rpm for 10-20 minutes, and then concentrated under reduced pressure at 65 ° C. or lower. It is preferable to use an extract having a moisture content of 36-40%. If you use more than% (w / v), there is a problem of strong taste and sedimentation, and if you use less than 1% by weight (w / v), you may not be aware of the flavor of red ginseng's unique taste and the problem may be reduced. .
생약성분 농축액의 원료가 되는 생약재로는 당귀, 천궁, 숙지황 및 백작약이 사용되는데, 옛부터 이들 생약재를 동량의 비로 배합시킨 사물탕 처방이 여성의 산후피로회복, 월경불순 등에 효능이 있는 것으로 알려져 왔다.The herbal medicines used as the raw materials of the herbal medicine concentrates are Angelica, Cheonggung, Sukjihwang and Baekjak, which have long been known to be effective in recovering women's postpartum fatigue and menstrual irregularities.
본 발명에 사용되는 생약성분 농축액은 생약재로 당귀, 천궁, 숙지황 및 백작약을 동량의 비율로 혼합하여 정제수를 생약재대비 5-10배량 가하고 70-90℃에서 3-5시간 동안 추출하는 공정을 3회 반복하여 얻은 각각의 추출액을 혼합하여 15-25℃에서 8,000rpm으로 10-20분간 원심분리한 후, 65℃이하에서 감압농축시킨 것으로 수분함량이 36∼40%인 추출액을 사용하는 것이 바람직한데, 생약성분 농축액을 6 중량% (w/v) 이상 사용하면 생약향취미가 너무 강하고 침전발생 등의 문제가 있고, 2 중량% (w/v) 이하로 사용하면 맛이 약해지며 효능발현이 약화되는 문제가 발생한다.Herbal medicine concentrate used in the present invention is a herbal medicine mixed with Angelica, Cheonggung, Sukjiwang and Baekjak at the same ratio by adding 5-10 times the amount of purified water compared to the herbal medicine and three times the extraction process for 3-5 hours at 70-90 ℃ Each of the extracts obtained repeatedly was mixed and centrifuged at 8,000 rpm for 10-20 minutes at 15-25 ° C., and then concentrated under reduced pressure at 65 ° C. or lower. It is preferable to use an extract having a moisture content of 36 to 40%. If the herbal ingredient concentrate is used more than 6% by weight (w / v), the herbal flavor taste is too strong and there is a problem such as sedimentation, and when used below 2% by weight (w / v), the taste becomes weak and the efficacy expression is weakened. A problem arises.
본 발명에 사용되는 피크노제놀(pycnogenol)은 강력한 항산화작용, 항염증작용, 비타민 C의 생체내 작용에 대한 증강작용, 노인의 뇌혈류 장애개선, 피부미용 효과, 만성피로 증후군에 대한 개선 및 치료효과 등이 있는데, 이중 항산화작용은 활성산소 제거효과 측면에서 비교할 때 비타민 C의 20배 정도의 효과를 지니는 것으로, 피크노제놀을 0.2 중량% (w/v) 이상 사용하면 일일섭취량을 초과하며 원가부담상승의 문제가 있고, 0.05 중량% (w/v) 이하로 사용하면 일일섭취량의 미달로 효능의 결여되는 문제가 발생한다.Pycnogenol used in the present invention is potent antioxidant activity, anti-inflammatory action, enhancement of vitamin C in vivo action, improvement of cerebral blood flow disorder in elderly, skin care effect, improvement and treatment effect for chronic fatigue syndrome, etc. The antioxidant activity is about 20 times more effective than vitamin C in terms of free radical scavenging effect. The use of pycnogenol in excess of 0.2% by weight (w / v) exceeds the daily intake and raises the cost burden. There is a problem of lack of efficacy due to less than the daily intake when using less than 0.05% by weight (w / v).
본 발명에 사용되는 타우린(taurine)은 아미노산의 일종으로 문어, 오징어등에 함유되어 있으며, 항산화작용, 심장보호, 세포내 독성물질 제거, 알코올해독, 지방조직에서의 지방대사촉진, 뇌세포 보호작용 등의 기능을 한다.Taurine (taurine) used in the present invention is a kind of amino acid contained in octopus, squid, etc., antioxidant activity, cardiac protection, removal of intracellular toxic substances, alcohol detoxification, promoting fat metabolism in adipose tissue, protecting brain cells, etc. Function of.
본 발명에 사용되는 D-솔비톨(D-sorbitol)은 당알코올의 일종으로서, 섭취시 구강내에서 청량감을 느끼게 해주며 인공감미료와 혼합하여 사용하면 설탕과 같은 칼로리를 내기 때문에 인공감미료만으로서 얻지 못하는 칼로리를 얻을 수 있을 뿐 아니라 감미도의 상승효과 및 인공감미료의 감미를 개량시킬 수 있고, 타당류보다 장내에서의 흡수가 느려서 비타민 B군의 섭취량을 감소시키는 기능을 한다.D-sorbitol (D-sorbitol) used in the present invention is a kind of sugar alcohol, makes it feel refreshing in the oral cavity when ingested, and when used in combination with artificial sweeteners because it produces calories like sugar, it can not be obtained only as artificial sweeteners Not only calories can be obtained, but the synergistic effect of sweetness and the sweetness of artificial sweeteners can be improved, and absorption in the intestine is slower than that of sugars, thus reducing the intake of vitamin B group.
본 발명에 사용되는 감미료는 설탕, 포도당, 꿀과 같은 천연감미료 뿐만 아니라 사카린(saccharine), 시클라메이트(cyclamate), 아스파탐(aspartame), 아세설팜-K(acesulfame-K), 스테비오사이드(stevioside) 등과 같은 인공감미료 모두가 사용될 수 있으나, 아세설팜-K, 아스파탐 등과 같은 저칼로리 감미료를 사용하는 것이 바람직하다.Sweeteners used in the present invention is not only natural sweeteners such as sugar, glucose, honey, but also saccharine, cyclamate, aspartame, acesulfame-K, stevioside Both artificial sweeteners such as) may be used, but it is preferable to use low calorie sweeteners such as acesulfame-K, aspartame and the like.
본 발명에 사용되는 비타민 B군은 B1(thiamine), B2(ribiflavin), B6(pyridoxine, pyridoxal, pyridoxamine), B12(cyanocobalamin) 등이 혼합되어 있는 것이 바람직하나, 순수한 것 대신에 다른 B군 비타민이 혼합되어 있는 조제품을 사용할 수도 있다.Vitamin B group used in the present invention is preferably a mixture of B1 (thiamine), B2 (ribiflavin), B6 (pyridoxine, pyridoxal, pyridoxamine), B12 (cyanocobalamin), etc. Mixed preparations may be used.
또한, 본 발명에 사용되는 과실향은 Fruit mix림팩, Pineapple mixflavor 등이 사용될 수 있다.In addition, the fruit flavor used in the present invention may be used Fruit mix rim pack, Pineapple mixflavor and the like.
이하 본 발명의 내용을 실시예를 통하여 구체적으로 설명하도록 한다. 그러나 다음의 실시예는 본 발명을 보다 상세하게 설명하기 위한 것으로, 본 발명의 권리범위를 이에 한정하고자 하는 것은 아니다.Hereinafter, the content of the present invention will be described in detail through examples. However, the following examples are intended to illustrate the present invention in more detail, and the scope of the present invention is not intended to be limited thereto.
<실시예 1><Example 1>
홍삼의 동체와 미삼을 80 : 20의 비율로 혼합하여 정제수를 홍삼대비 10배량 가하고 80℃에서 8시간 동안 추출(1차 추출)하여 냉각시킨 다음, 1차 추출후 남은 홍삼의 동체와 미삼 혼합물에 정제수를 홍삼대비 5배량 가하고 80℃에서 8시간 동안 추출하는 공정을 2회 반복하여 냉각시킨 2차 및 3차 추출액과 1차 추출액을 혼합하여 8,000rpm으로 10분 동안 원심분리한 후, 65℃ 이하에서 감압농축시켜 수분함량 38%의 홍삼농축액을 얻었다.The body and red ginseng of red ginseng are mixed at a ratio of 80: 20, and purified water is added 10 times more than the red ginseng, and extracted by cooling (primary extraction) for 8 hours at 80 ° C. Add 5 times the amount of purified water to red ginseng, and extract the secondary and tertiary extracts and the primary extract, which were repeatedly cooled at 80 ° C. for 8 hours, and centrifuged at 8,000 rpm for 10 minutes. The red ginseng concentrate was obtained by concentrating under reduced pressure at 38%.
생약재로 당귀, 천궁, 숙지황 및 백작약을 동량의 비율로 혼합하여 정제수를 생약재 대비 10배량 가하고 80℃에서 4시간 동안 추출(1차 추출)하여 냉각시킨 다음, 1차 추출후 남은 생약재에 정제수를 생약재 대비 5배량 가하고 80℃에서 4시간 동안 추출하는 공정을 2회 반복하여 냉각시킨 2차 및 3차 추출액과 1차 추출액을 혼합하여 20℃에서 8,000rpm으로 10분 동안 원심분리한 후, 65℃ 이하에서 감압농축시켜 수분함량 38%의 생약성분 농축액을 얻었다.As a herbal medicine, Angelica, Cheongung, Sukji-hwang and Baekjak were mixed in equal proportions. 10 times the amount of purified water was added to the herbal medicine, extracted at 80 ° C. for 4 hours (first extraction), cooled, and the purified water was added to the remaining herbal medicine after the first extraction. After adding 5 times the amount and extracting the extract for 4 hours at 80 ℃, the secondary and tertiary extracts and primary extracts were cooled and mixed twice, centrifuged at 8,000 rpm for 10 minutes at 20 ℃, 65 ℃ or less The extract was concentrated under reduced pressure at to obtain a herbal ingredient concentrate having a water content of 38%.
상기의 공정에서 얻은 홍삼농축액 2 중량% (w/v), 생약성분 농축액 4 중량% (w/v) 및 피크노제놀 0.1 중량% (w/v), D-솔비톨 15 중량% (w/v), 타우린 2 중량%(w/v), 아세설팜-K 0.03 중량% (w/v), 비타민 B군 0.03 중량% (w/v), 과실향( Raspberry + Strawberry mixflavor) 0.1 중량%(w/v)를 혼합하고 정제수를 첨가하여 균질화한 다음 음료용기에 충전, 포장한 후 살균하여 홍삼음료를 제조하였다.2% by weight (w / v) of red ginseng concentrate obtained in the above process, 4% by weight of herbal ingredient concentrate (w / v), 0.1% by weight of pycnogenol (w / v), 15% by weight of D-sorbitol (w / v), 2% by weight taurine (w / v), 0.03% by weight acesulfame-K (w / v), 0.03% by weight vitamin B (w / v), 0.1% by weight (w / v Raspberry + Strawberry mixflavor) v) was mixed, homogenized by adding purified water, and then filled and packed in a beverage container and sterilized to prepare a red ginseng beverage.
<실시예 2><Example 2>
홍삼의 동체와 미삼을 80 : 20의 비율로 혼합하여 정제수를 홍삼대비 10배량 가하고 70℃에서 9시간 동안 추출(1차 추출)하여 냉각시킨 다음, 1차 추출후 남은 홍삼의 동체와 미삼 혼합물에 정제수를 홍삼대비 5배량 가하고 70℃에서 9시간 동안 추출하는 공정을 2회 반복하여 냉각시킨 2차 및 3차 추출액과 1차 추출액을 혼합하여 8,000rpm으로 15분 동안 원심분리한 후, 65℃ 이하에서 감압농축시켜 수분함량 36%의 홍삼농축액을 얻었다.The body and red ginseng of red ginseng are mixed at a ratio of 80: 20, and purified water is added 10 times more than the red ginseng, and extracted by cooling (primary extraction) for 9 hours at 70 ° C. After adding 5 times the amount of purified water to red ginseng and extracting at 70 ° C. for 9 hours, the mixture of the secondary and tertiary extracts and the primary extract were cooled twice, centrifuged at 8,000 rpm for 15 minutes, and then 65 ° C. or lower. The red ginseng concentrate was obtained by concentrating under reduced pressure at 36% moisture content.
생약재로 당귀, 천궁, 숙지황 및 백작약을 동량의 비율로 혼합하여 정제수를 생약재 대비 10배량 가하고 70℃에서 5시간 동안 추출(1차 추출)하여 냉각시킨 다음, 1차 추출후 남은 생약재에 정제수를 생약재 대비 5배량 가하고 70℃에서 5시간 동안 추출하는 공정을 2회 반복하여 냉각시킨 2차 및 3차 추출액과 1차 추출액을 혼합하여 20℃에서 8,000rpm으로 10분 동안 원심분리한 후, 65℃ 이하에서 감압농축시켜 수분함량 40%의 생약성분 농축액을 얻었다.As a herbal medicine, Donggwi, Cheongung, Sukjihwang and Baekjak were mixed in equal proportions. 10 times the amount of purified water was added to the herbal medicine and extracted (primary extraction) for 5 hours at 70 ° C, and then purified water was added to the remaining herbal medicine after the first extraction. After adding 5 times compared to the extraction process for 5 hours at 70 ℃, the secondary and tertiary extracts and primary extracts were cooled and mixed twice, centrifuged at 8,000 rpm for 10 minutes at 20 ℃, 65 ℃ or less The extract was concentrated under reduced pressure at to obtain a herbal ingredient concentrate having a water content of 40%.
상기의 공정에서 얻은 홍삼농축액 3 중량% (w/v), 생약성분 농축액 2 중량% (w/v) 및 피크노제놀 0.05 중량% (w/v), D-솔비톨 10 중량% (w/v), 타우린 1 중량% (w/v), 아세설팜-K 0.05 중량% (w/v), 비타민 B군 0.06 중량% (w/v),과실향(Raspberry + Strawberry mixflavor) 0.15 중량%(w/v)를 혼합하고 정제수를 첨가하여 균질화한 다음 음료용기에 충전, 포장한 후 살균하여 홍삼음료를 제조하였다.3% by weight (w / v) of red ginseng concentrate obtained in the above process, 2% by weight (w / v) of herbal ingredient concentrate, 0.05% by weight (w / v) of pycnogenol, 10% by weight of D-sorbitol (w / v), 1% by weight of taurine (w / v), 0.05% by weight of acesulfame-K (w / v), 0.06% by weight of vitamin B group (w / v), 0.15% by weight of raspberry + Strawberry mixflavor (w / v) v) was mixed, homogenized by adding purified water, and then filled and packed in a beverage container and sterilized to prepare a red ginseng beverage.
<실시예 3><Example 3>
홍삼의 동체와 미삼을 80 : 20의 비율로 혼합하여 정제수를 홍삼대비 10배량 가하고 90℃에서 7시간 동안 추출(1차 추출)하여 냉각시킨 다음, 1차 추출후 남은 홍삼의 동체와 미삼 혼합물에 정제수를 홍삼대비 5배량 가하고 90℃에서 7시간 동안 추출하는 공정을 2회 반복하여 냉각시킨 2차 및 3차 추출액과 1차 추출액을 혼합하여 8,000rpm으로 20분 동안 원심분리한 후, 65℃ 이하에서 감압농축시켜 수분함량 36%의 홍삼농축액을 얻었다.The body and red ginseng of red ginseng are mixed at a ratio of 80: 20, and purified water is added 10 times more than the red ginseng, and extracted by cooling (primary extraction) at 90 ° C. for 7 hours. After adding 5 times the amount of purified water to red ginseng and extracting the mixture for 2 hours at 90 ° C., the mixture of the secondary and tertiary extracts and the primary extract were cooled and centrifuged at 8,000 rpm for 20 minutes. The red ginseng concentrate was obtained by concentrating under reduced pressure at 36% moisture content.
생약재로 당귀, 천궁, 숙지황 및 백작약을 동량의 비율로 혼합하여 정제수를 생약재 대비 10배량 가하고 90℃에서 3시간 동안 추출(1차 추출)하여 냉각시킨 다음, 1차 추출후 남은 생약재에 정제수를 생약재 대비 5배량 가하고 90℃에서 3시간 동안 추출하는 공정을 2회 반복하여 냉각시킨 2차 및 3차 추출액과 1차 추출액을 혼합하여 20℃에서 8,000rpm으로 10분 동안 원심분리한 후, 65℃ 이하에서 감압농축시켜 수분함량 40%의 생약성분 농축액을 얻었다.As a medicinal herb, Angelica, Cheongung, Sukji-hwang and Baekjak were mixed in equal proportions, and purified water was added 10 times more than the herbal medicine and extracted (first extraction) at 90 ° C. for 3 hours, cooled and then purified water was added to the remaining herbal medicine after the first extraction. After adding 5 times the amount and extracting the mixture for 2 hours at 90 ℃, the secondary and tertiary extract and the primary extract was cooled and mixed twice, centrifuged at 8,000 rpm for 10 minutes at 20 ℃, 65 ℃ or less The extract was concentrated under reduced pressure at to obtain a herbal ingredient concentrate having a water content of 40%.
상기의 공정에서 얻은 홍삼농축액 1 중량% (w/v), 생약성분 농축액 6 중량% (w/v) 및 피크노제놀 0.2 중량% (w/v), D-솔비톨 20 중량% (w/v), 타우린 3 중량% (w/v), 아세설팜-K 0.01 중량% (w/v), 비타민 B군 0.01 중량% (w/v), 과실향 (Raspberry + Strawberry mixflavor) 0.05 중량%(w/v)를 혼합하고 정제수를 첨가하여 균질화한 다음 음료용기에 충전, 포장한 후 살균하여 홍삼음료를 제조하였다.1% by weight red ginseng concentrate (w / v) obtained in the above process, 6% by weight herbal extract (w / v), 0.2% by weight pycnogenol (w / v), 20% by weight D-sorbitol (w / v), Taurine 3 wt% (w / v), Acesulfame-K 0.01 wt% (w / v), Vitamin B group 0.01 wt% (w / v), Fruit flavor (Raspberry + Strawberry mixflavor) 0.05 wt% (w / v) was mixed, homogenized by adding purified water, and then filled and packed in a beverage container and sterilized to prepare a red ginseng beverage.
<시험예><Test Example>
본 발명에 의한 홍삼음료의 기호도와 복용의 편리성을 평가하기 위하여 관능검사를 실시한 결과를 표 1에 나타내었는데, 수치가 높을수록 양호함을 의미한다.In order to evaluate the palatability and convenience of taking red ginseng beverage according to the present invention, the results of the sensory test are shown in Table 1, but the higher the value, the better.
관능검사는 20-60세 남녀 20 명을 대상으로 5점 척도법에 의하여 실시예 1 내지 실시예 3에서 제조한 홍삼음료의 종합적인 맛, 편리성 및 상품성을 평가하였는데, 표 1의 결과는 그 평균치를 나타낸 것으로 대조군은 시중에 시판중인 생약성분과 피크노제놀이 함유되지 않은 홍삼음료를 사용하였다.The sensory test was conducted to evaluate the overall taste, convenience, and merchandise of the red ginseng beverages prepared in Examples 1 to 3 using a 5-point scale method for 20 males and females 20-60 years old. The control group used commercially available herbal medicine and red ginseng drink that does not contain pycnogenol.
<표 1>. 관능검사 결과TABLE 1 Sensory test result
본 발명에 의한 홍삼음료는 홍삼농축액과 생약재, 피크노제놀, 타우린 등과 같은 항산화작용 증진제를 함유하여 노화억제 및 갱년기증상 완화기능을 갖을 뿐만 아니라, 감미료, 비타민 및 과실향 등과 같은 첨가제를 함유하고 있어 기호도 및 복용의 편리성 등이 개선되어 건강음료로 사용될 수 있다.Red ginseng drink according to the present invention contains antioxidants such as red ginseng concentrate and herbal medicine, pycnogenol, taurine, etc. to have anti-aging and menopausal symptoms, as well as additives such as sweeteners, vitamins and fruit flavors. Convenience of taking is improved and can be used as a health drink.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0068353A KR100411021B1 (en) | 2001-11-03 | 2001-11-03 | A drink containing the red ginseng, and a method for preparing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0068353A KR100411021B1 (en) | 2001-11-03 | 2001-11-03 | A drink containing the red ginseng, and a method for preparing thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030037379A KR20030037379A (en) | 2003-05-14 |
KR100411021B1 true KR100411021B1 (en) | 2003-12-18 |
Family
ID=29567858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0068353A KR100411021B1 (en) | 2001-11-03 | 2001-11-03 | A drink containing the red ginseng, and a method for preparing thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100411021B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100737271B1 (en) | 2005-04-21 | 2007-07-09 | 주식회사 청보건강 | Functional Beverage Production Method Using Fresh Ginseng and Red Ginseng Concentrate and Its Beverages |
KR102425775B1 (en) | 2021-06-30 | 2022-07-27 | 길병헌 | Method for manufacturing red ginseng drink |
KR20220135282A (en) | 2021-03-29 | 2022-10-07 | 영동대벤처식품 (주) | Manufacturing method of functional health drink containing Korean red ginseng and grape juice |
KR20230068468A (en) | 2021-11-10 | 2023-05-18 | 영동대벤처식품 (주) | Manufacturing method of functional health drink containing peach juice |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100821631B1 (en) * | 2002-08-17 | 2008-04-16 | (주)아모레퍼시픽 | Herbal Skin Care Food Composition |
KR100833208B1 (en) * | 2006-12-08 | 2008-05-28 | 금산고려홍삼 주식회사 | Red ginseng and herbal medicine |
KR101144920B1 (en) * | 2009-08-19 | 2012-05-11 | 주식회사 청송제약 | An Extract with Red Ginseng and Herbs |
KR101375347B1 (en) * | 2013-08-01 | 2014-03-18 | 금산군 | The method for manufacuting red ginseng drink with medicinal herb, and the red ginseng drink made by the method |
KR101505103B1 (en) * | 2013-08-13 | 2015-03-26 | 주식회사 천지양 | Improved method for preparing red ginseng extracts using repeated extraction |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1036279A (en) * | 1996-07-18 | 1998-02-10 | Ichimaru Pharcos Co Ltd | Fibroblast proliferation promoting agent containing vegetable extract |
KR980000453A (en) * | 1996-06-05 | 1998-03-30 | 박명규 | Ginseng drink and soft capsule |
KR980000175A (en) * | 1996-06-05 | 1998-03-30 | 박명규 | Ginseng drink having a memory enhancing action and its manufacturing method |
JPH10150959A (en) * | 1997-10-01 | 1998-06-09 | Takeda Chem Ind Ltd | Liquid composition for beverage |
KR19980076028A (en) * | 1997-04-04 | 1998-11-16 | 박명규 | Sports Science Ginseng Products and Manufacturing Method |
KR100217923B1 (en) * | 1996-01-18 | 1999-09-01 | 이상준 | Ginseng processing method and proceed ginseng prepared by the same |
KR19990070812A (en) * | 1998-02-24 | 1999-09-15 | 조원기 | Functional stress relief drink |
KR20030028328A (en) * | 2001-09-29 | 2003-04-08 | 주식회사 케이티앤지 | Ginseng food for strengthening study efficacy and the preparing method |
-
2001
- 2001-11-03 KR KR10-2001-0068353A patent/KR100411021B1/en active IP Right Grant
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100217923B1 (en) * | 1996-01-18 | 1999-09-01 | 이상준 | Ginseng processing method and proceed ginseng prepared by the same |
KR980000453A (en) * | 1996-06-05 | 1998-03-30 | 박명규 | Ginseng drink and soft capsule |
KR980000175A (en) * | 1996-06-05 | 1998-03-30 | 박명규 | Ginseng drink having a memory enhancing action and its manufacturing method |
JPH1036279A (en) * | 1996-07-18 | 1998-02-10 | Ichimaru Pharcos Co Ltd | Fibroblast proliferation promoting agent containing vegetable extract |
KR19980076028A (en) * | 1997-04-04 | 1998-11-16 | 박명규 | Sports Science Ginseng Products and Manufacturing Method |
JPH10150959A (en) * | 1997-10-01 | 1998-06-09 | Takeda Chem Ind Ltd | Liquid composition for beverage |
KR19990070812A (en) * | 1998-02-24 | 1999-09-15 | 조원기 | Functional stress relief drink |
KR20030028328A (en) * | 2001-09-29 | 2003-04-08 | 주식회사 케이티앤지 | Ginseng food for strengthening study efficacy and the preparing method |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100737271B1 (en) | 2005-04-21 | 2007-07-09 | 주식회사 청보건강 | Functional Beverage Production Method Using Fresh Ginseng and Red Ginseng Concentrate and Its Beverages |
KR20220135282A (en) | 2021-03-29 | 2022-10-07 | 영동대벤처식품 (주) | Manufacturing method of functional health drink containing Korean red ginseng and grape juice |
KR102425775B1 (en) | 2021-06-30 | 2022-07-27 | 길병헌 | Method for manufacturing red ginseng drink |
KR20230068468A (en) | 2021-11-10 | 2023-05-18 | 영동대벤처식품 (주) | Manufacturing method of functional health drink containing peach juice |
Also Published As
Publication number | Publication date |
---|---|
KR20030037379A (en) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080038367A1 (en) | Nutritional supplement compositions and methods of preparing | |
Bakhru | Foods that heal: The natural way to good health | |
WO2008021861A2 (en) | Rehydration beverage | |
ES2261796T3 (en) | COMPOSITION FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCIES THAT INCLUDES A RED VID LEAF EXTRACT. | |
KR100411021B1 (en) | A drink containing the red ginseng, and a method for preparing thereof | |
CN106962934A (en) | A kind of alcohol-decomposing beverage based on Tea Saponin | |
KR101202988B1 (en) | Healthy beverage and its manufacturing method | |
CN102846963B (en) | A kind ofly promote relieving alcoholic intoxication and anti-intoxication Chinese medicine extract complex preparation and its preparation method and application | |
KR20110013685A (en) | Functional beverage composition containing marine deep water, fermented black ginger extract and jujube concentrate | |
CN103251698B (en) | A kudzu root drinking liquid with anti-alcoholic, liver-protecting and stomach-protecting effects and its preparation method | |
CN107348438A (en) | A kind of health-care honey with effect of relaxing bowel and preparation method thereof | |
KR100392876B1 (en) | A drink for eliminating a hangover and a method for producing the same | |
CN109497466A (en) | A kind of low cane sugar type composite brown sugar | |
KR100509983B1 (en) | Healthy food composition for accelerating growth | |
KR20100077781A (en) | Method for preparing functional powder to improve erectile dysfunction and assistance food comprising the functional powder | |
CN112155143A (en) | Instant solid beverage with skin care and beauty function and preparation method thereof | |
KR100496524B1 (en) | Composition for eliminating hangover | |
CN102335251A (en) | Composition with effect of relieving alcoholism, and preparation method thereof | |
KR100444395B1 (en) | A healthful food using red ginseng extract, and a method for preparing thereof | |
KR101080458B1 (en) | Composition of health beverage | |
CN111317081A (en) | Beverage with beauty maintaining and young keeping functions | |
KR100376941B1 (en) | Hematic green tea and method for preparation thereof | |
KR20110029280A (en) | Herbal soap composition | |
RU2792449C2 (en) | Composition of phytotea containing biologically active additives | |
KR20210041387A (en) | A natural tea removing the effect of hangover contained the extract material in arrowroot blossoms and Plantago ovata |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20011103 |
|
PA0201 | Request for examination | ||
N231 | Notification of change of applicant | ||
PN2301 | Change of applicant |
Patent event date: 20021214 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20031029 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20031202 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20031203 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20061026 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20071019 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20080912 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20091103 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20110517 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20111230 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20121127 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20121127 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20131125 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20131125 Start annual number: 11 End annual number: 11 |
|
FPAY | Annual fee payment |
Payment date: 20141121 Year of fee payment: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20141121 Start annual number: 12 End annual number: 12 |
|
FPAY | Annual fee payment |
Payment date: 20151130 Year of fee payment: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20151130 Start annual number: 13 End annual number: 13 |
|
FPAY | Annual fee payment |
Payment date: 20161130 Year of fee payment: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20161130 Start annual number: 14 End annual number: 14 |
|
FPAY | Annual fee payment |
Payment date: 20171128 Year of fee payment: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20171128 Start annual number: 15 End annual number: 15 |
|
FPAY | Annual fee payment |
Payment date: 20191114 Year of fee payment: 17 |
|
PR1001 | Payment of annual fee |
Payment date: 20191114 Start annual number: 17 End annual number: 17 |
|
PC1801 | Expiration of term |
Termination date: 20220503 Termination category: Expiration of duration |